Feature Learning with Multi-Stage Vision Transformers on Inter-Modality HER2 Status Scoring and Tumor Classification on Whole Slides
Olaide N. Oyelade, Oliver Hoxey, and Yulia Humrye

TL;DR
This paper introduces a vision transformer-based pipeline for accurate HER2 status scoring and tumor classification on whole slide images, integrating H&E and IHC data for pixel-level HER2 annotation.
Contribution
It presents a novel end-to-end system combining patch-wise processing, a mapping function, and a HER2 scoring mechanism using vision transformers, enabling joint analysis of H&E and IHC images.
Findings
Achieved 0.94 accuracy in HER2 status prediction.
Demonstrated effective tumor localization with good accuracy.
Validated the method's usability compared to human pathologists.
Abstract
The popular use of histopathology images, such as hematoxylin and eosin (H&E), has proven to be useful in detecting tumors. However, moving such cancer cases forward for treatment requires accurate on the amount of the human epidermal growth factor receptor 2 (HER2) protein expression. Predicting both the lower and higher levels of HER2 can be challenging. Moreover, jointly analyzing H&E and immunohistochemistry (IHC) stained images for HER2 scoring is difficult. Although several deep learning methods have been investigated to address the challenge of HER2 scoring, they suffer from providing a pixel-level localization of HER2 status. In this study, we propose a single end-to-end pipeline using a system of vision transformers with HER2 status scoring on whole slide images of WSIs. The method includes patch-wise processing of H&E WSIs for tumor localization. A novel mapping function is…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsAI in cancer detection · Digital Imaging for Blood Diseases · HER2/EGFR in Cancer Research
